Search dm+d | This AMP cannot be matched against our prescribing data.
| Description | Comirnaty JN.1 COVID-19 mRNA Vaccine 30micrograms/0.3ml dose dispersion for injection multidose vials (Pfizer Ltd) |
| BNF code | 1404000ATBGAKBS |
| Virtual Medicinal Product | Generic Comirnaty JN.1 COVID-19 mRNA Vaccine 30micrograms/0.3ml dose dispersion for injection multidose vials |
| Name | Comirnaty JN.1 COVID-19 mRNA Vaccine 30micrograms/0.3ml dose dispersion for injection multidose vials |
| Abbreviated name | Comirnaty JN.1 COVID-19 mRNA Vaccine 0.3ml inj md vials |
| Supplier | Pfizer Ltd |
| Current licensing authority | Medicines - MHRA/EMA |
| Previous licensing authority | None |
| Reason for change of licensing authority | Licence Granted |
| Date of change of licensing authority | 4 Sep 2024 |
| EMA additional monitoring | ✓ |
| Parallel import | ✗ |
| Restrictions on availability | Restricted Availability |
| Actual Medicinal Product Packs | |
|---|---|
| Comirnaty JN.1 COVID-19 mRNA Vaccine 30micrograms/0.3ml dose dispersion for injection multidose vials (Pfizer Ltd) 60 dose 10 x 6 dose vials | |
| Comirnaty JN.1 COVID-19 mRNA Vaccine 30micrograms/0.3ml dose dispersion for injection multidose vials (Pfizer Ltd) 6 dose | |
dm+d data retrieved from TRUD: release NHSBSA_11.3.0_20241125000001, imported on 26th November 2024 at 03:54:16.